using Pradaxa (dabigatran) for more than atrial fibrillation
We're getting questions about using Pradaxa (dabigatran) for more than atrial fibrillation.
There's some evidence for other indications...but these aren't FDA approved and there are other limitations.
Treating venous thromboembolism. Pradaxa 150 mg BID for 6 months seems to work as well as warfarin to treat acute deep venous thrombosis or pulmonary embolism...and has a similar bleeding risk.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote